Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Long-Term Follow-Up Basket Study for Participants Treated With SynKIR Chimeric Antigen Receptor (CAR) T Cell Product
Sponsor: Verismo Therapeutics
Summary
The primary purpose of this study is to monitor potential long-term risks associated with the administration of SynKIR CAR T cell products.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
60
Start Date
2025-01-27
Completion Date
2042-02
Last Updated
2026-02-10
Healthy Volunteers
No
Conditions
Interventions
SynKIR-110
Autologous T cells Transduced with Mesothelin KIR-CAR
SynKIR-310
Autologous T Cells transduced with CD19 KIR-CAR
Locations (6)
Colorado Blood Cancer Institute, part of Sarah Cannon Research Institute
Denver, Colorado, United States
Winship Cancer Institute of Emory University
Atlanta, Georgia, United States
University of Kansas Cancer Center
Westwood, Kansas, United States
University of Pennsylvania Abramson Cancer Center
Philadelphia, Pennsylvania, United States
MD Anderson Cancer Center
Houston, Texas, United States
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States